Related references
Note: Only part of the references are listed.The Critical Role of the Pathologist in Determining Eligibility for Active Surveillance as a Management Option in Patients With Prostate Cancer Consensus Statement With Recommendations Supported by the College of American Pathologists, International Society of Urological Pathology, Association of Directors of Anatomic and Surgical Pathology, the New Zealand Society of Pathologists, and the Prostate Cancer Foundation
Mahul B. Amin et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2014)
Multi-institutional Validation of the CAPRA-S Score to Predict Disease Recurrence and Mortality After Radical Prostatectomy
Sanoj Punnen et al.
EUROPEAN UROLOGY (2014)
PTEN loss in biopsy tissue predicts poor clinical outcomes in prostate cancer
Prabhakar Mithal et al.
INTERNATIONAL JOURNAL OF UROLOGY (2014)
Downgrading of biopsy based Gleason score in prostatectomy specimens
Kilian M. Treurniet et al.
JOURNAL OF CLINICAL PATHOLOGY (2014)
Prognostic Histopathological and Molecular Markers on Prostate Cancer Needle-Biopsies: A Review
A. Marije Hoogland et al.
BIOMED RESEARCH INTERNATIONAL (2014)
A Model for the Design and Construction of a Resource for the Validation of Prognostic Prostate Cancer Biomarkers: The Canary Prostate Cancer Tissue Microarray
Sarah Hawley et al.
ADVANCES IN ANATOMIC PATHOLOGY (2013)
Active surveillance for low-risk prostate cancer
Chris H. Bangma et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2013)
Overdiagnosis and Overtreatment in Cancer An Opportunity for Improvement
Laura J. Esserman et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2013)
Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update
Antonio C. Wolff et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
PTEN losses exhibit heterogeneity in multifocal prostatic adenocarcinoma and are associated with higher Gleason grade
Maisa Yoshimoto et al.
MODERN PATHOLOGY (2013)
Clinical Versus Pathologic Staging for Prostate Adenocarcinoma How Do They Correlate?
Ellen W. Cooke et al.
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2012)
Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
Antje Krohn et al.
AMERICAN JOURNAL OF PATHOLOGY (2012)
Implications of the International Society of Urological Pathology Modified Gleason Grading System
Lars Egevad et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2012)
Systematic, evidence-based discovery of biomarkers at the NCI
John R. Prensner et al.
CLINICAL & EXPERIMENTAL METASTASIS (2012)
Will Biomarkers Save Prostate Cancer Screening?
Matthew R. Cooperberg
EUROPEAN UROLOGY (2012)
Active Surveillance for Prostate Cancer: A Systematic Review of the Literature
Marc A. Dall'Era et al.
EUROPEAN UROLOGY (2012)
Upgrading and Downgrading of Prostate Cancer from Biopsy to Radical Prostatectomy: Incidence and Predictive Factors Using the Modified Gleason Grading System and Factoring in Tertiary Grades
Jonathan I. Epstein et al.
EUROPEAN UROLOGY (2012)
PTEN genomic deletions that characterize aggressive prostate cancer originate close to segmental duplications
Maisa Yoshimoto et al.
GENES CHROMOSOMES & CANCER (2012)
Loss of PTEN expression is associated with increased risk of recurrence after prostatectomy for clinically localized prostate cancer
Alcides Chaux et al.
MODERN PATHOLOGY (2012)
Prostate-Cancer Mortality at 11 Years of Follow-up
Fritz H. Schroder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
PTEN genomic deletion is an early event associated with ERG gene rearrangements in prostate cancer
Tarek A. Bismar et al.
BJU INTERNATIONAL (2011)
Changes in Prostate Cancer Grade on Serial Biopsy in Men Undergoing Active Surveillance
Sima P. Porten et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Predicting 15-Year Prostate Cancer Specific Mortality After Radical Prostatectomy
Scott E. Eggener et al.
JOURNAL OF UROLOGY (2011)
Molecular characterisation of ERG, ETV1 and PTEN gene loci identifies patients at low and high risk of death from prostate cancer
A. H. M. Reid et al.
BRITISH JOURNAL OF CANCER (2010)
TMPRSS2-ERG gene fusion is associated with low Gleason scores and not with high-grade morphological features
Samson W. Fine et al.
MODERN PATHOLOGY (2010)
Cancer Screening: The Clash of Science and Intuition
Barnett S. Kramer et al.
ANNUAL REVIEW OF MEDICINE (2009)
Overexpression of Prostate-Specific TMPRSS2(exon 0)-ERG Fusion Transcripts Corresponds with Favorable Prognosis of Prostate Cancer
Karin G. Hermans et al.
CLINICAL CANCER RESEARCH (2009)
PTEN genomic deletion is associated with p-Akt and AR signalling in poorer outcome, hormone refractory prostate cancer
Kanishka Sircar et al.
JOURNAL OF PATHOLOGY (2009)
Lead Time and Overdiagnosis in Prostate-Specific Antigen Screening: Importance of Methods and Context
Gerrit Draisma et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Prostate Cancer Diagnosis and Treatment After the Introduction of Prostate-Specific Antigen Screening: 1986-2005
H. Gilbert Welch et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
TMPRSS2-ETS fusion prostate cancer: Biological and clinical implications
Francesca Demichelis et al.
JOURNAL OF CLINICAL PATHOLOGY (2007)
FISH analysis of 107 prostate cancers shows that PTEN genomic deletion is associated with poor clinical outcome
M. Yoshimoto et al.
BRITISH JOURNAL OF CANCER (2007)
Determining risk of biochemical recurrence in prostate cancer by immunohistochemical detection of PTEN expression end Akt activation
Roble Bedolla et al.
CLINICAL CANCER RESEARCH (2007)
Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: The American Urological Association Prostate Guidelines for Localized Prostate Cancer update panel report and recommendations for a standard in the reporting of surgical outcomes
Michael S. Cookson et al.
JOURNAL OF UROLOGY (2007)
FISH analysis for the detection of lymphoma-associated chromosomal abnormalities in routine paraffin-embedded tissue
Roland A. Ventura et al.
JOURNAL OF MOLECULAR DIAGNOSTICS (2006)
Share Paper
